{"id":68897,"date":"2026-03-02T18:06:52","date_gmt":"2026-03-02T18:06:52","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&p=68897"},"modified":"2026-05-21T07:14:11","modified_gmt":"2026-05-21T07:14:11","slug":"ipamorelin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nl\/ipamorelin\/","title":{"rendered":"Ipamorelin"},"content":{"rendered":"

<\/p>\n

\n

Quick Answer \u2014 What is Ipamorelin?<\/h3>\n

Ipamorelin<\/strong> is a synthetic pentapeptide growth-hormone secretagogue that binds the ghrelin receptor (GHS-R1a) to trigger pulsatile GH release zonder<\/strong> raising cortisol or prolactin \u2014 a selectivity that distinguishes it from older GHRPs. In research it is frequently stacked with CJC-1295 to amplify GH pulse amplitude. Supplied in 2\u00a0mg to 10\u00a0mg lyophilized vials for laboratory research use only.<\/p>\n<\/div>\n

Wat u krijgt bij MedsBase:<\/strong> Onderzoekskwaliteit lyofiliseerde peptiden \u00b7 HPLC \u226599% zuiverheid (COA op aanvraag) \u00b7 Discrete temperatuurstabiele verpakking \u00b7 Wereldwijde peptidekoerier \u00b7 1.400+ geverifieerd klantbeoordelingen<\/a><\/div>\n

\ud83d\udce6 Elke bestelling is gedekt door onze Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Specificatie<\/th>\nDetail<\/th>\n<\/tr>\n<\/thead>\n
CAS-nummer<\/strong><\/td>\n170851-70-4<\/td>\n<\/tr>\n
Molecuulformule<\/strong><\/td>\nC38<\/sub>H49<\/sub>N9<\/sub>O5<\/sub><\/td>\n<\/tr>\n
Moleculair gewicht<\/strong><\/td>\n711.86 Da<\/td>\n<\/tr>\n
Sequentie<\/strong><\/td>\nAib-His-D-2-Nal-D-Phe-Lys-NH2<\/sub><\/td>\n<\/tr>\n
Form<\/strong><\/td>\nLyofiliseerd poeder (of zoals geleverd)<\/td>\n<\/tr>\n
Zuiverheid<\/strong><\/td>\n\u226599% (HPLC geverifieerd, COA op aanvraag)<\/td>\n<\/tr>\n
Opslag<\/strong><\/td>\nLyofiliseerd: 2\u20138 \u00b0C (koelkast) voor werkvoorraad; \u221220 \u00b0C voor langdurige opslag van ongeopende flesjes. Gereconstitueerd: 2\u20138 \u00b0C, gebruik binnen ~30 dagen. Bescherm tegen licht. Vries de gereconstitueerde oplossing niet in en ontdooi deze niet.<\/td>\n<\/tr>\n
Oplosbaarheid<\/strong><\/td>\nBacteriostatisch water (aanbevolen) of steriel water voor kortere gebruiksperioden<\/td>\n<\/tr>\n
Onderzoeksgebruik<\/strong><\/td>\nAlleen voor laboratoriumonderzoek. Niet voor humaan of veterinair diagnostisch of therapeutisch gebruik.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/p>\n

What Is Ipamorelin?<\/h2>\n

Ipamorelin<\/strong> is a synthetic pentapeptide belonging to the growth-hormone-releasing peptide (GHRP) family. Developed by Novo Nordisk in the 1990s and first characterised by Raun et al. (Eur J Endocrinol, 1998), it is classified as a growth hormone secretagogue<\/strong> \u2014 a compound that triggers endogenous GH release by activating the ghrelin receptor (GHS-R1a) on pituitary somatotropes.<\/p>\n

Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2<\/sub>. Molecular weight approximately 711.9\u00a0Da. Unlike earlier GHRPs (GHRP-2, GHRP-6, hexarelin), ipamorelin is remarkable for its clean hormonal selectivity<\/strong> \u2014 it releases GH without meaningfully raising cortisol, prolactin, or ACTH. This selectivity is why ipamorelin has become the most-studied GHRP of the 21st century. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. Ipamorelin is uitsluitend voor laboratoriumonderzoek<\/strong> and is not intended for human or veterinary diagnosis or therapy. For mechanism, published research, and stacking protocols, see our Ipamorelin & CJC-1295 research guide<\/a>.<\/p>\n

Mechanism of Action \u2014 Selective Ghrelin-Receptor Agonism<\/h2>\n

Ipamorelin binds the growth hormone secretagogue receptor type 1a (GHS-R1a)<\/strong>, the endogenous receptor for ghrelin. The receptor is expressed on pituitary somatotropes and in the hypothalamic arcuate nucleus, and activation triggers a pulsatile release of growth hormone from pituitary storage granules.<\/p>\n